Report Detail
Global Gastrointestinal Stromal Tumors Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
- RnM4626373 |
- 10 September, 2025 |
- Global |
- 81 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumors Therapeutics market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Gastrointestinal Stromal Tumors Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gastrointestinal Stromal Tumors Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumors Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumors Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumors Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastrointestinal Stromal Tumors Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastrointestinal Stromal Tumors Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ascentage Pharma Group International, Bayer AG, Blueprint Medicines Corp, Bristol Myers Squibb Co., Deciphera Pharmaceuticals Inc, Immunicum AB, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Xencor Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gastrointestinal Stromal Tumors Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Non-oral
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumors Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Stromal Tumors Therapeutics, with revenue, gross margin, and global market share of Gastrointestinal Stromal Tumors Therapeutics from 2020 to 2025.
Chapter 3, the Gastrointestinal Stromal Tumors Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gastrointestinal Stromal Tumors Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumors Therapeutics.
Chapter 13, to describe Gastrointestinal Stromal Tumors Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Gastrointestinal Stromal Tumors Therapeutics by Type
- 1.3.1 Overview: Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Gastrointestinal Stromal Tumors Therapeutics Consumption Value Market Share by Type in 2024
- 1.3.3 Oral
- 1.3.4 Non-oral
- 1.4 Global Gastrointestinal Stromal Tumors Therapeutics Market by Application
- 1.4.1 Overview: Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Gastrointestinal Stromal Tumors Therapeutics Market Size & Forecast
- 1.6 Global Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region, (2020-2031)
- 1.6.3 North America Gastrointestinal Stromal Tumors Therapeutics Market Size and Prospect (2020-2031)
- 1.6.4 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size and Prospect (2020-2031)
- 1.6.6 South America Gastrointestinal Stromal Tumors Therapeutics Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Ascentage Pharma Group International
- 2.1.1 Ascentage Pharma Group International Details
- 2.1.2 Ascentage Pharma Group International Major Business
- 2.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.1.4 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Ascentage Pharma Group International Recent Developments and Future Plans
- 2.2 Bayer AG
- 2.2.1 Bayer AG Details
- 2.2.2 Bayer AG Major Business
- 2.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.2.4 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Bayer AG Recent Developments and Future Plans
- 2.3 Blueprint Medicines Corp
- 2.3.1 Blueprint Medicines Corp Details
- 2.3.2 Blueprint Medicines Corp Major Business
- 2.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.3.4 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Blueprint Medicines Corp Recent Developments and Future Plans
- 2.4 Bristol Myers Squibb Co.
- 2.4.1 Bristol Myers Squibb Co. Details
- 2.4.2 Bristol Myers Squibb Co. Major Business
- 2.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.4.4 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Bristol Myers Squibb Co. Recent Developments and Future Plans
- 2.5 Deciphera Pharmaceuticals Inc
- 2.5.1 Deciphera Pharmaceuticals Inc Details
- 2.5.2 Deciphera Pharmaceuticals Inc Major Business
- 2.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.5.4 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Deciphera Pharmaceuticals Inc Recent Developments and Future Plans
- 2.6 Immunicum AB
- 2.6.1 Immunicum AB Details
- 2.6.2 Immunicum AB Major Business
- 2.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.6.4 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Immunicum AB Recent Developments and Future Plans
- 2.7 Novartis AG
- 2.7.1 Novartis AG Details
- 2.7.2 Novartis AG Major Business
- 2.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.7.4 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Novartis AG Recent Developments and Future Plans
- 2.8 Pfizer Inc.
- 2.8.1 Pfizer Inc. Details
- 2.8.2 Pfizer Inc. Major Business
- 2.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.8.4 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Pfizer Inc. Recent Developments and Future Plans
- 2.9 Sun Pharmaceutical Industries Ltd
- 2.9.1 Sun Pharmaceutical Industries Ltd Details
- 2.9.2 Sun Pharmaceutical Industries Ltd Major Business
- 2.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.9.4 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
- 2.10 Xencor Inc.
- 2.10.1 Xencor Inc. Details
- 2.10.2 Xencor Inc. Major Business
- 2.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product and Solutions
- 2.10.4 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Xencor Inc. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Gastrointestinal Stromal Tumors Therapeutics Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Gastrointestinal Stromal Tumors Therapeutics by Company Revenue
- 3.2.2 Top 3 Gastrointestinal Stromal Tumors Therapeutics Players Market Share in 2024
- 3.2.3 Top 6 Gastrointestinal Stromal Tumors Therapeutics Players Market Share in 2024
- 3.3 Gastrointestinal Stromal Tumors Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Gastrointestinal Stromal Tumors Therapeutics Market: Region Footprint
- 3.3.2 Gastrointestinal Stromal Tumors Therapeutics Market: Company Product Type Footprint
- 3.3.3 Gastrointestinal Stromal Tumors Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Gastrointestinal Stromal Tumors Therapeutics Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global Gastrointestinal Stromal Tumors Therapeutics Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Type (2020-2031)
- 6.2 North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2020-2031)
- 6.3 North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
- 6.3.1 North America Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Country (2020-2031)
- 6.3.2 United States Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 6.3.3 Canada Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Type (2020-2031)
- 7.2 Europe Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Application (2020-2031)
- 7.3 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
- 7.3.1 Europe Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Country (2020-2031)
- 7.3.2 Germany Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 7.3.3 France Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 7.3.5 Russia Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 7.3.6 Italy Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Region (2020-2031)
- 8.3.2 China Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 8.3.3 Japan Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 8.3.5 India Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 8.3.7 Australia Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Type (2020-2031)
- 9.2 South America Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Application (2020-2031)
- 9.3 South America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
- 9.3.1 South America Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
- 10.3.4 UAE Gastrointestinal Stromal Tumors Therapeutics Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Gastrointestinal Stromal Tumors Therapeutics Market Drivers
- 11.2 Gastrointestinal Stromal Tumors Therapeutics Market Restraints
- 11.3 Gastrointestinal Stromal Tumors Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Gastrointestinal Stromal Tumors Therapeutics Industry Chain
- 12.2 Gastrointestinal Stromal Tumors Therapeutics Upstream Analysis
- 12.3 Gastrointestinal Stromal Tumors Therapeutics Midstream Analysis
- 12.4 Gastrointestinal Stromal Tumors Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gastrointestinal Stromal Tumors Therapeutics. Industry analysis & Market Report on Gastrointestinal Stromal Tumors Therapeutics is a syndicated market report, published as Global Gastrointestinal Stromal Tumors Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Gastrointestinal Stromal Tumors Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
